Related references
Note: Only part of the references are listed.Prevalence and pharmacological modulation of humoral immunity to AAV vectors in gene transfer to synovial tissue
F. Mingozzi et al.
GENE THERAPY (2013)
Flushing Out Antibodies to Make AAV Gene Therapy Available to More Patients
Steven E. Raper et al.
MOLECULAR THERAPY (2013)
Intracellular transport of recombinant adeno-associated virus vectors
M. Nonnenmacher et al.
GENE THERAPY (2012)
Humoral and Cellular Capsid-Specific Immune Responses to Adeno-Associated Virus Type 1 in Randomized Healthy Donors
Philippe Veron et al.
JOURNAL OF IMMUNOLOGY (2012)
Mapping a Neutralizing Epitope onto the Capsid of Adeno-Associated Virus Serotype 8
Brittney L. Gurda et al.
JOURNAL OF VIROLOGY (2012)
Europe gives gene therapy the green light
Karl Gruber
LANCET (2012)
Pharmacological Modulation of Humoral Immunity in a Nonhuman Primate Model of AAV Gene Transfer for Hemophilia B
Federico Mingozzi et al.
MOLECULAR THERAPY (2012)
The AAV Vector Toolkit: Poised at the Clinical Crossroads
Aravind Asokan et al.
MOLECULAR THERAPY (2012)
Adeno-Associated Virus Antibody Profiles in Newborns, Children, and Adolescents
Roberto Calcedo et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Impact of Pre-Existing Immunity on Gene Transfer to Nonhuman Primate Liver with Adeno-Associated Virus 8 Vectors
Lili Wang et al.
HUMAN GENE THERAPY (2011)
Phase 2 Clinical Trial of a Recombinant Adeno-Associated Viral Vector Expressing α1-Antitrypsin: Interim Results
Terence R. Flotte et al.
HUMAN GENE THERAPY (2011)
The Assembly-Activating Protein Promotes Capsid Assembly of Different Adeno-Associated Virus Serotypes
F. Sonntag et al.
JOURNAL OF VIROLOGY (2011)
A 10 Patient Case Report on the Impact of Plasmapheresis Upon Neutralizing Factors Against Adeno-associated Virus (AAV) Types 1, 2, 6, and 8
Virginie Monteilhet et al.
MOLECULAR THERAPY (2011)
Adenovirus-Associated Virus Vector-Mediated Gene Transfer in Hemophilia B
Amit C. Nathwani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Enhancing the clinical potential of AAV vectors by capsid engineering to evade pre-existing immunity
Melissa Bartel et al.
FRONTIERS IN MICROBIOLOGY (2011)
Random Mutagenesis Methods for In Vitro Directed Enzyme Evolution
Nikolaos E. Labrou
CURRENT PROTEIN & PEPTIDE SCIENCE (2010)
Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors
Sylvie Boutin et al.
HUMAN GENE THERAPY (2010)
Preexisting Immunity and Low Expression in Primates Highlight Translational Challenges for Liver-directed AAV8-mediated Gene Therapy
Gregory D. Hurlbut et al.
MOLECULAR THERAPY (2010)
A viral assembly factor promotes AAV2 capsid formation in the nucleolus
Florian Sonntag et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Optimization of stealth adeno-associated virus vectors by randomization of immunogenic epitopes
Stephan Maersch et al.
VIROLOGY (2010)
AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells
Federico Mingozzi et al.
BLOOD (2009)
Worldwide Epidemiology of Neutralizing Antibodies to Adeno-Associated Viruses
Roberto Calcedo et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Diverse IgG Subclass Responses to Adeno-Associated Virus Infection and Vector Administration
Samuel L. Murphy et al.
JOURNAL OF MEDICAL VIROLOGY (2009)
Creating protein biocatalysts as tools for future industrial applications
John C. Chaput et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2008)
Coating of adeno-associated virus with reactive polymers can ablate virus tropsim, enable retargeting and provide resistance to neutralising antisera
Robert C. Carlisle et al.
JOURNAL OF GENE MEDICINE (2008)
Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver
Federico Mingozzi et al.
BLOOD (2007)
Combinatorial engineering of a gene therapy vector:: directed evolution of adeno-associated virus
L Perabo et al.
JOURNAL OF GENE MEDICINE (2006)
Directed evolution of adeno-associated virus yields enhanced gene delivery vectors
N Maheshri et al.
NATURE BIOTECHNOLOGY (2006)
Mutations on the external surfaces of adeno-associated virus type 2 capsids that affect transduction and neutralization
MA Lochrie et al.
JOURNAL OF VIROLOGY (2006)
Utility of PEGylated recombinant adeno-associated viruses for gene transfer
HT Le et al.
JOURNAL OF CONTROLLED RELEASE (2005)
PEG conjugation moderately protects adeno-associated viral vectors against antibody neutralization
GK Lee et al.
BIOTECHNOLOGY AND BIOENGINEERING (2005)
Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models
AM Davidoff et al.
MOLECULAR THERAPY (2005)
Clades of Adeno-associated viruses are widely disseminated in human tissues
GP Gao et al.
JOURNAL OF VIROLOGY (2004)
Effect of pegylation on pharmaceuticals
JM Harris et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
PEGylation of E1-deleted adenovirus vectors allows significant gene expression on readministration to liver
MA Croyle et al.
HUMAN GENE THERAPY (2002)
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
GP Gao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Stealth adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung
MA Croyle et al.
JOURNAL OF VIROLOGY (2001)
Productive replication of adeno-associated virus can occur in human papillomavirus type 16 (HPV-16) episome-containing keratinocytes and is augmented by the HPV-16 E2 protein
P Ogston et al.
JOURNAL OF VIROLOGY (2000)
Epitope mapping of human anti-adeno-associated virus type 2 neutralizing antibodies: Implications for gene therapy and virus structure
M Moskalenko et al.
JOURNAL OF VIROLOGY (2000)
Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes
CL Halbert et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
